Patents by Inventor Herve Lang

Herve Lang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of PTHrP antagonists for treating renal cell carcinoma
    Patent number: 7727526
    Abstract: The present invention concerns the use of a PTHrP antagonist for preparing a pharmaceutical composition for treating renal cell carcinoma (RCC) in a mammal and in particular in a human subject. Advantageously, the invention is of particular interest for inhibiting or reducing tumour growth and/or metastasis formation in kidney cancer and its metastatic developments, in particular in the lung and the liver.
    Type: Grant
    Filed: July 4, 2003
    Date of Patent: June 1, 2010
    Assignees: Universite Louis Pasteur, Institut National de la Sante et de la Recherche Medicale (INSERM), Hopitaux Universitaires de Strasbourg
    Inventors: Thierry Massfelder, Herve Lang, Eric Schordan, Jean-Jacques Helwig
  • Method for the in vitro diagnosis of a predisposition to bladder cancer or of the occurrence of bladder cancer and a kit for performing said diagnostic method
    Publication number: 20030113758
    Abstract: A new in vitro method for diagnosing the predisposition of a human individual to bladder cancer or for diagnosing the occurrence of a bladder cancer in a human individual, makes use of a comparison between the allelic ratios of a serial of microsatellite markers associated with this disease, respectively in the urine DNA and in the blood cell DNA of said human individual.
    Type: Application
    Filed: August 14, 2002
    Publication date: June 19, 2003
    Inventors: Pierre Oudet, Didier Jacqmin, Marie-Pierre Gaub, Anne Schneider, Herve Lang